These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 18690552)

  • 1. The truth of treating patients with phenylketonuria after childhood: the need for a new guideline.
    van Spronsen FJ; Burgard P
    J Inherit Metab Dis; 2008 Dec; 31(6):673-9. PubMed ID: 18690552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of phenylketonuria for optimal outcome: a review of guidelines for phenylketonuria management and a report of surveys of parents, patients, and clinic directors.
    Wappner R; Cho S; Kronmal RA; Schuett V; Seashore MR
    Pediatrics; 1999 Dec; 104(6):e68. PubMed ID: 10586002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updated, web-based nutrition management guideline for PKU: An evidence and consensus based approach.
    Singh RH; Cunningham AC; Mofidi S; Douglas TD; Frazier DM; Hook DG; Jeffers L; McCune H; Moseley KD; Ogata B; Pendyal S; Skrabal J; Splett PL; Stembridge A; Wessel A; Rohr F
    Mol Genet Metab; 2016 Jun; 118(2):72-83. PubMed ID: 27211276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suboptimal outcomes in patients with PKU treated early with diet alone: revisiting the evidence.
    Enns GM; Koch R; Brumm V; Blakely E; Suter R; Jurecki E
    Mol Genet Metab; 2010; 101(2-3):99-109. PubMed ID: 20678948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key European guidelines for the diagnosis and management of patients with phenylketonuria.
    van Spronsen FJ; van Wegberg AM; Ahring K; Bélanger-Quintana A; Blau N; Bosch AM; Burlina A; Campistol J; Feillet F; Giżewska M; Huijbregts SC; Kearney S; Leuzzi V; Maillot F; Muntau AC; Trefz FK; van Rijn M; Walter JH; MacDonald A
    Lancet Diabetes Endocrinol; 2017 Sep; 5(9):743-756. PubMed ID: 28082082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
    Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
    Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimising growth in phenylketonuria: current state of the clinical evidence base.
    Dokoupil K; Gokmen-Ozel H; Lammardo AM; Motzfeldt K; Robert M; Rocha JC; van Rijn M; Ahring K; Bélanger-Quintana A; MacDonald A
    Clin Nutr; 2012 Feb; 31(1):16-21. PubMed ID: 21959353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal serum phenylalanine for adult patients with phenylketonuria.
    Okano Y; Nagasaka H
    Mol Genet Metab; 2013 Dec; 110(4):424-30. PubMed ID: 24094552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
    Weglage J; Fromm J; van Teeffelen-Heithoff A; Möller HE; Koletzko B; Marquardt T; Rutsch F; Feldmann R
    Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-year retrospective analysis of patients with phenylketonuria (PKU) and hyperphenylalaninemia treated at two specialized clinics.
    Levy H; Lamppu D; Anastosoaie V; Baker JL; DiBona K; Hawthorne S; Lindenberger J; Kinch D; Seymour A; McIlduff M; Watling S; Vockley J
    Mol Genet Metab; 2020 Mar; 129(3):177-185. PubMed ID: 31883647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to clinic recommendations among patients with phenylketonuria in the United States.
    Jurecki ER; Cederbaum S; Kopesky J; Perry K; Rohr F; Sanchez-Valle A; Viau KS; Sheinin MY; Cohen-Pfeffer JL
    Mol Genet Metab; 2017 Mar; 120(3):190-197. PubMed ID: 28162992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acid profile in patients with phenylketonuria and its relationship with bone mineral density.
    Lage S; Bueno M; Andrade F; Prieto JA; Delgado C; Legarda M; Sanjurjo P; Aldámiz-Echevarría LJ
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S363-71. PubMed ID: 20830525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenylketonuria Scientific Review Conference: state of the science and future research needs.
    Camp KM; Parisi MA; Acosta PB; Berry GT; Bilder DA; Blau N; Bodamer OA; Brosco JP; Brown CS; Burlina AB; Burton BK; Chang CS; Coates PM; Cunningham AC; Dobrowolski SF; Ferguson JH; Franklin TD; Frazier DM; Grange DK; Greene CL; Groft SC; Harding CO; Howell RR; Huntington KL; Hyatt-Knorr HD; Jevaji IP; Levy HL; Lichter-Konecki U; Lindegren ML; Lloyd-Puryear MA; Matalon K; MacDonald A; McPheeters ML; Mitchell JJ; Mofidi S; Moseley KD; Mueller CM; Mulberg AE; Nerurkar LS; Ogata BN; Pariser AR; Prasad S; Pridjian G; Rasmussen SA; Reddy UM; Rohr FJ; Singh RH; Sirrs SM; Stremer SE; Tagle DA; Thompson SM; Urv TK; Utz JR; van Spronsen F; Vockley J; Waisbren SE; Weglicki LS; White DA; Whitley CB; Wilfond BS; Yannicelli S; Young JM
    Mol Genet Metab; 2014 Jun; 112(2):87-122. PubMed ID: 24667081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes beyond phenylalanine: an international perspective.
    Feillet F; MacDonald A; Hartung Perron D; Burton B
    Mol Genet Metab; 2010; 99 Suppl 1():S79-85. PubMed ID: 20123476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Untreated PKU Patients without Intellectual Disability: What Do They Teach Us?
    van Vliet D; van Wegberg AMJ; Ahring K; Bik-Multanowski M; Casas K; Didycz B; Djordjevic M; Hertecant JL; Leuzzi V; Mathisen P; Nardecchia F; Powell KK; Rutsch F; Stojiljkovic M; Trefz FK; Usurelu N; Wilson C; van Karnebeek CD; Hanley WB; van Spronsen FJ
    Nutrients; 2019 Oct; 11(11):. PubMed ID: 31731404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow up of phenylketonuria patients.
    Demirkol M; Giżewska M; Giovannini M; Walter J
    Mol Genet Metab; 2011; 104 Suppl():S31-9. PubMed ID: 22018725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future treatment strategies in phenylketonuria.
    van Spronsen FJ; Enns GM
    Mol Genet Metab; 2010; 99 Suppl 1():S90-5. PubMed ID: 20123478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over Restriction of Dietary Protein Allowance: The Importance of Ongoing Reassessment of Natural Protein Tolerance in Phenylketonuria.
    Pinto A; Almeida MF; MacDonald A; Ramos PC; Rocha S; Guimas A; Ribeiro R; Martins E; Bandeira A; Jackson R; van Spronsen F; Payne A; Rocha JC
    Nutrients; 2019 Apr; 11(5):. PubMed ID: 31052331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy compliance in children with phenylketonuria younger than 5 years: A cohort study.
    Walkowiak D; Bukowska-Posadzy A; Kałużny Ł; Ołtarzewski M; Staszewski R; Musielak M; Walkowiak J
    Adv Clin Exp Med; 2019 Oct; 28(10):1385-1391. PubMed ID: 31469949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain phenylalanine concentration in the management of adults with phenylketonuria.
    Moats RA; Koch R; Moseley K; Guldberg P; Guttler F; Boles RG; Nelson MD
    J Inherit Metab Dis; 2000 Feb; 23(1):7-14. PubMed ID: 10682303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.